Hospital Virgen de la Salud
11
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
9.1%
1 terminated/withdrawn out of 11 trials
85.7%
-0.8% vs industry average
45%
5 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
INOCA Spanish National Registry
Role: collaborator
Postextubation High-flow Therapy vs Noninvasive Ventilation in Obese or at High-risk Patients
Role: lead
Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis
Role: collaborator
Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP)
Role: lead
Left Atrial Geometry and Outcomes After Atrial Fibrillation Ablation
Role: collaborator
Imatinib in KIT-negative Systemic Mastocytosis
Role: lead
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Role: lead
Sleep Apnea-hypopnea Syndrome (SAHS) and Ventricular Arrhythmias
Role: collaborator
Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab
Role: lead
Does Deflating the Tracheal Cuff Shorten Weaning Time?
Role: lead
Efficacy of Non-Invasive Mechanical Ventilation in Early Hypoxia Secondary to Thoracic Trauma
Role: lead
All 11 trials loaded